Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析

◆英語タイトル:Mithra Pharmaceuticals SA (MITRA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH220680FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mithra Pharmaceuticals SA (Mithra) develops and manufactures over the counter products for women’s health and other applications. The company offers various drug products such as donesta, estelle, tibelia, myring, and zoreline. Its products are used in the treatment of contraception and fertility, gynecological infections, menopause and osteoporosis; and cancers. Mithra offers its products in polymeric forms, hormonal tablets, and sterile injectable products. The company offers services such as drug development and supporting services. It offers its products under various brands such as PeriNesta, Tibelia, Estelle, and Donesta. The company offers its products through a network of distributors in Belgium, France, Germany, Luxemburg, and Brazil. Mithra is headquartered in Liege, Belgium.

Mithra Pharmaceuticals SA Key Recent Developments

Mar 31,2021: tranScrip is proud to be associated with a unique new oestrogen which has received its first product approvals
Mar 09,2021: Mithra Reports Full Year 2020 Financial Results
Mar 09,2021: Mithra Reports Full Year 2020 Financial Results
Mar 04,2021: Mithra to Host Webcast for 2020 Financial Results on 9 March 2021

This comprehensive SWOT profile of Mithra Pharmaceuticals SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mithra Pharmaceuticals SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mithra Pharmaceuticals SA – Key Information
Mithra Pharmaceuticals SA – Overview
Mithra Pharmaceuticals SA – Key Employees
Mithra Pharmaceuticals SA – Key Employee Biographies
Mithra Pharmaceuticals SA – Key Operational Heads
Mithra Pharmaceuticals SA – Major Products and Services
Mithra Pharmaceuticals SA – History
Mithra Pharmaceuticals SA – Company Statement
Mithra Pharmaceuticals SA – Locations And Subsidiaries
Mithra Pharmaceuticals SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mithra Pharmaceuticals SA – Business Description
Mithra Pharmaceuticals SA – Corporate Strategy
Mithra Pharmaceuticals SA – SWOT Analysis
SWOT Analysis – Overview
Mithra Pharmaceuticals SA – Strengths
Mithra Pharmaceuticals SA – Weaknesses
Mithra Pharmaceuticals SA – Opportunities
Mithra Pharmaceuticals SA – Threats
Mithra Pharmaceuticals SA – Key Competitors

Section 3 – Company Financial Performance Charts

Mithra Pharmaceuticals SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mithra Pharmaceuticals SA, Key Information
Mithra Pharmaceuticals SA, Key Ratios
Mithra Pharmaceuticals SA, Share Data
Mithra Pharmaceuticals SA, Major Products and Services
Mithra Pharmaceuticals SA, History
Mithra Pharmaceuticals SA, Key Employees
Mithra Pharmaceuticals SA, Key Employee Biographies
Mithra Pharmaceuticals SA, Key Operational Heads
Mithra Pharmaceuticals SA, Other Locations
Mithra Pharmaceuticals SA, Subsidiaries
Mithra Pharmaceuticals SA, Key Competitors
Mithra Pharmaceuticals SA, SWOT Analysis
Mithra Pharmaceuticals SA, Ratios based on current share price
Mithra Pharmaceuticals SA, Annual Ratios
Mithra Pharmaceuticals SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alviva Holdings Ltd (AVV):企業の財務・戦略的SWOT分析
    Alviva Holdings Ltd (AVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • InVitae Corp (NVTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Invitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and generates test reports for clinicians and their patients. The company’s portfolio of diagnostic t …
  • PT. Indonesia Power:企業の戦略的SWOT分析
    PT. Indonesia Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Endo International Plc (ENDP)-医療機器分野:企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • Harte Hanks Inc (HHS):企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Atlas Copco AB:企業の戦略・SWOT・財務情報
    Atlas Copco AB - Strategy, SWOT and Corporate Finance Report Summary Atlas Copco AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Progenity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Grundfos Holding AS:企業の戦略的SWOT分析
    Grundfos Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Community Health Systems Inc (CYH):製薬・医療:M&Aディール及び事業提携情報
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • Sypris Solutions, Inc.:企業の戦略・SWOT・財務分析
    Sypris Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sypris Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Magnolia Petroleum Plc (MAGP):企業の財務・戦略的SWOT分析
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Stockmann plc (STCBV):企業の財務・戦略的SWOT分析
    Stockmann plc (STCBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mississippi Power Co:企業の戦略的SWOT分析
    Mississippi Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Orlando Utilities Commission:企業の戦略的SWOT分析
    Orlando Utilities Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Nexus AG (NXU):企業の財務・戦略的SWOT分析
    Summary Nexus AG (Nexus) is a healthcare technology company that provides healthcare software solutions. The company provides products such as NEXUS and HIS, a hospital information system; NEXUS and DIS, a special ward and department solutions; and NEXUS and QM, a solution in quality management, amo …
  • Orezone Gold Corporation:企業の戦略・SWOT・財務情報
    Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Golden Grain Energy LLC:企業の戦略的SWOT分析
    Golden Grain Energy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Koninklijke Philips N.V. (PHIA):電力:M&Aディール及び事業提携情報
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare soluti …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆